Go Back
Lux Capital
Lux Capital, a New York-based venture fund established in 2000, focuses on investing in early-stage science and tech ventures across a wide range of industries. Lux Capital has made 403 investments and has seen 47 exits. The fund, led by partner Adam Goulburn, targets various sectors including BioTech, Healthcare, Artificial Intelligence & Machine Learning, Robotics, FinTech, and Consumer Electronics. Lux Capital's diverse portfolio includes companies like H1, Maven Clinic, Flutterwave, Happiest Baby, and Clarifai. Lux Capital's website is www.luxcapital.com.
About
About
About
Bio
Lux Capital is an investment firm investing in counter-conventional, early-stage science, and tech ventures.
Location
New York
Stage
Pre-Seed, Seed, Series A, Series B, Series C, Series D
Partner name
Adam Goulburn
Bio
Lux Capital is an investment firm investing in counter-conventional, early-stage science, and tech ventures.
Location
New York
Stage
Pre-Seed, Seed, Series A, Series B, Series C, Series D
Partner name
Adam Goulburn
Fund
Fund
Fund
Fund Focus
BioTech, Healthcare, Life Science, Medical Device, Big Data & Analytics, Artificial Intelligence & Machine Learning (AI/ML), Entertainment & Media, Developer Tools, CloudTech, Information Technology, PaaS (Platforms), SaaS, Parenting, Professional Services, InsurTech, Health & Wellness, Construction Tech, Software, FinTech, Robotics, SpaceTech, Manufacturing, Supply Chain Tech, Telecommunications (TMT), IoT (Internet of Things), Consulting, Legal Tech, E-Sports (Gaming), Hardware, Augmented & Virtual Reality (AR/VR), Pharmaceuticals, Advanced Materials, Market Research, Transportation, Consumer Electronics, Food and Beverage, Cryptocurrency / Blockchain, Sports, PropTech, B2B, Productivity Tools, Enterprise, Cybersecurity, DeepTech, Industrials, Apps, Wearables & Quantified Self, Emerging Markets, Logistics, Risk Management, Privacy, HR Tech, Hospitality, Computer, Nanotechnology, AssistiveTech, Consumer, FoodTech, Mobile
Number of investments
403
Number of exits
47
Fund Type
Venture Fund
Portfolio Companies
H1, Primer, Vendia, LatchBio, Maven Clinic, Super, Miga Health, Eikon Therapeutics, OpenSpace, Mos, Sourcegraph, Tecton, Covariant, Flutterwave, Orbital Insight, Hadrian, Hugging Face, Astranis, Happiest Baby, DoNotPay, Survios, Kallyope, SteadyMD, Avail Medsystems, Genvid Technologies, Formic Technologies, Flex Logix Technologies, AllStripes, Tempo Automation, System, Alife, Kingdom Supercultures, Enveda Biosciences, Anchorage, Drone Racing League, Perchwell, Decent, Balanced, Epsilon3, Rivet, Parallel Markets, Variant Bio, Waymark, Gameto, Benchling, Clarifai, Fiddler AI, Strangeworks, Octant Bio, Yonder, Tendo, Ripcord, Paceline, Plexium, Saildrone, Pager, Strateos, Cala Health, Umba, Looking Glass Factory, Dyno Therapeutics, Stord, Workit Health, Aptible, Cloaked, ZEDEDA, Neo.Tax, Ahana, Onaroll, HumanFirst, Nanosys, Pivotal Commware, Mahana Therapeutics, Aira, Pinscreen, Higharc, Multiply Labs, Shiru, Echodyne
Lux Capital
Lux Capital, a New York-based venture fund established in 2000, focuses on investing in early-stage science and tech ventures across a wide range of industries. Lux Capital has made 403 investments and has seen 47 exits. The fund, led by partner Adam Goulburn, targets various sectors including BioTech, Healthcare, Artificial Intelligence & Machine Learning, Robotics, FinTech, and Consumer Electronics. Lux Capital's diverse portfolio includes companies like H1, Maven Clinic, Flutterwave, Happiest Baby, and Clarifai. Lux Capital's website is www.luxcapital.com.
About
Bio
Lux Capital is an investment firm investing in counter-conventional, early-stage science, and tech ventures.
Location
New York
Stage
Pre-Seed, Seed, Series A, Series B, Series C, Series D
Partner name
Adam Goulburn
Fund
Fund Focus
BioTech, Healthcare, Life Science, Medical Device, Big Data & Analytics, Artificial Intelligence & Machine Learning (AI/ML), Entertainment & Media, Developer Tools, CloudTech, Information Technology, PaaS (Platforms), SaaS, Parenting, Professional Services, InsurTech, Health & Wellness, Construction Tech, Software, FinTech, Robotics, SpaceTech, Manufacturing, Supply Chain Tech, Telecommunications (TMT), IoT (Internet of Things), Consulting, Legal Tech, E-Sports (Gaming), Hardware, Augmented & Virtual Reality (AR/VR), Pharmaceuticals, Advanced Materials, Market Research, Transportation, Consumer Electronics, Food and Beverage, Cryptocurrency / Blockchain, Sports, PropTech, B2B, Productivity Tools, Enterprise, Cybersecurity, DeepTech, Industrials, Apps, Wearables & Quantified Self, Emerging Markets, Logistics, Risk Management, Privacy, HR Tech, Hospitality, Computer, Nanotechnology, AssistiveTech, Consumer, FoodTech, Mobile
Number of investments
403
Number of exits
47
Fund Type
Venture Fund
Portfolio Companies
H1, Primer, Vendia, LatchBio, Maven Clinic, Super, Miga Health, Eikon Therapeutics, OpenSpace, Mos, Sourcegraph, Tecton, Covariant, Flutterwave, Orbital Insight, Hadrian, Hugging Face, Astranis, Happiest Baby, DoNotPay, Survios, Kallyope, SteadyMD, Avail Medsystems, Genvid Technologies, Formic Technologies, Flex Logix Technologies, AllStripes, Tempo Automation, System, Alife, Kingdom Supercultures, Enveda Biosciences, Anchorage, Drone Racing League, Perchwell, Decent, Balanced, Epsilon3, Rivet, Parallel Markets, Variant Bio, Waymark, Gameto, Benchling, Clarifai, Fiddler AI, Strangeworks, Octant Bio, Yonder, Tendo, Ripcord, Paceline, Plexium, Saildrone, Pager, Strateos, Cala Health, Umba, Looking Glass Factory, Dyno Therapeutics, Stord, Workit Health, Aptible, Cloaked, ZEDEDA, Neo.Tax, Ahana, Onaroll, HumanFirst, Nanosys, Pivotal Commware, Mahana Therapeutics, Aira, Pinscreen, Higharc, Multiply Labs, Shiru, Echodyne